First results from Guinea's early Ebola vaccine trials For the first time since the west African Ebola outbreak began over a year ago, a clinical trial with a candidate treatment has yielded "encouraging" results, researchers announced Thursday. The trial with 80 patients in Guinea resulted in fewer deaths and faster recovery rates, the French government and medical research agency Inserm said of tests with the Japanese-manufactured anti-viral drug favipiravir. IMAGES AND SOUNDBITES of the press conference announcing first results from Guinea's early Ebola vaccine trials